Global Pharmaceuticals & Biotech Large Cap High Growth Potential

Ascendis Pharma

Market Cap: US$10.2b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Alnylam Pharmaceuticals

Market Cap: US$34.1b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

ALTEOGEN

Market Cap: ₩18.7t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Exelixis

Market Cap: US$10.8b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Neurocrine Biosciences

Market Cap: US$10.7b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

argenx

Market Cap: €34.7b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Beijing Wantai Biological Pharmacy Enterprise

Market Cap: CN¥82.8b

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

BeiGene

Market Cap: US$28.0b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Vertex Pharmaceuticals

Market Cap: US$131.0b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Torrent Pharmaceuticals

Market Cap: ₹1.1t

Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

Sandoz Group

Market Cap: CHF 15.4b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

AstraZeneca

Market Cap: UK£164.5b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

GSK

Market Cap: UK£59.2b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Illumina

Market Cap: US$12.3b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Galderma Group

Market Cap: CHF 22.8b

Operates as a dermatology company worldwide.

Sartorius Stedim Biotech

Market Cap: €20.1b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Innovent Biologics

Market Cap: HK$88.6b

A biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People’s Republic of China.

Daiichi Sankyo Company

Market Cap: JP¥6.8t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

AbbVie

Market Cap: US$345.1b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Incyte

Market Cap: US$12.1b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Lonza Group

Market Cap: CHF 41.6b

Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

Celltrion

Market Cap: ₩34.5t

Develops and produces drugs based on proteins for the treatment of oncology in South Korea.

Teva Pharmaceutical Industries

Market Cap: US$17.8b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Eli Lilly

Market Cap: US$807.2b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Novo Nordisk

Market Cap: DKK 2.0t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.7b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Natera

Market Cap: US$20.5b

A diagnostics company, provides molecular testing services worldwide.

Viatris

Market Cap: US$10.1b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Roche Holding

Market Cap: CHF 216.2b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

UCB

Market Cap: €30.6b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Eurofins Scientific

Market Cap: €10.0b

Provides various analytical testing and laboratory services worldwide.

Bayer

Market Cap: €22.6b

Operates as a life science company worldwide.

CSL

Market Cap: AU$121.6b

Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Genmab

Market Cap: DKK 87.2b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Divi's Laboratories

Market Cap: ₹1.6t

Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

WuXi Biologics (Cayman)

Market Cap: HK$92.4b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.